Evaluation of Pain Treatment After Total Knee Arthroplasty
ConditionPain
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorVertex Pharmaceuticals Incorporated
About this trial
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Eligibility criteria
Qualifiers
Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m²)
Scheduled to undergo an elective primary unilateral TKA surgery
Disqualifiers
None
Trial design
Treatments tested in this trial
- Suzetrigine
- Placebo
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov